https://www.selleckchem.com/pr....oducts/sch772984.htm
r studies with stronger study designs to gain better knowledge of causal factors of CFS/ME. Nonalcoholic steatohepatitis (NASH) is a form of liver disease characterized by steatosis, necroinflammation, and fibrosis, resulting in cirrhosis and cancer. Efforts have focused on reducing the intake of trans fatty acids (TFAs) because of potential hazards to human health and the increased risk for NASH. However, the health benefits of reducing dietary TFAs have not been fully elucidated. Here, the effects of TFAs vs. a substitute on NASH in
Mi piace
Commento
Condividi
